Clinical trial
A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly…
NCT00325962 · BioMarin Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00325962 |
|---|---|
| Title | A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension |
| Official title | A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension |
| Lead sponsor | BioMarin Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | 6R-BH4 (sapropterin dihydrochloride) |
| Enrollment | 84 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | May 15, 2006 |
| Last update posted | Jul 21, 2009 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: